rs10945673
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000335388.5(LPAL2):n.509-2435G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 151,990 control chromosomes in the GnomAD database, including 2,453 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.16 ( 2453 hom., cov: 32)
Consequence
LPAL2
ENST00000335388.5 intron
ENST00000335388.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.08
Publications
6 publications found
Genes affected
LPAL2 (HGNC:21210): (lipoprotein(a) like 2 (pseudogene)) Apolipoprotein(a) is the distinguishing protein moiety of lipoprotein(a), of which elevated plasma levels are correlated with an increased risk of atherosclerosis. This gene is similar to the lipoprotein, Lp(a) gene, but all transcripts produced by this gene contain a truncated open reading frame and are candidates for nonsense-mediated decay. Consequently, this gene is considered to be a pseudogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.33 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LPAL2 | ENST00000335388.5 | n.509-2435G>A | intron_variant | Intron 3 of 9 | 1 | |||||
| LPAL2 | ENST00000435757.6 | n.509-2435G>A | intron_variant | Intron 3 of 9 | 1 | |||||
| LPAL2 | ENST00000454031.6 | n.549+1496G>A | intron_variant | Intron 4 of 16 | 6 | |||||
| LPAL2 | ENST00000719164.1 | n.*98G>A | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.165 AC: 24995AN: 151870Hom.: 2451 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24995
AN:
151870
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.165 AC: 25007AN: 151990Hom.: 2453 Cov.: 32 AF XY: 0.167 AC XY: 12389AN XY: 74268 show subpopulations
GnomAD4 genome
AF:
AC:
25007
AN:
151990
Hom.:
Cov.:
32
AF XY:
AC XY:
12389
AN XY:
74268
show subpopulations
African (AFR)
AF:
AC:
3068
AN:
41468
American (AMR)
AF:
AC:
2786
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
AC:
612
AN:
3466
East Asian (EAS)
AF:
AC:
1774
AN:
5170
South Asian (SAS)
AF:
AC:
1264
AN:
4816
European-Finnish (FIN)
AF:
AC:
1860
AN:
10532
Middle Eastern (MID)
AF:
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
AC:
13007
AN:
67980
Other (OTH)
AF:
AC:
360
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1052
2104
3156
4208
5260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1112
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.